Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

EM011 compound MeSH Supplementary Concept Data 2025


MeSH Supplementary
EM011 compound
Unique ID
C510553
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C510553
Entry Term(s)
(S)-3-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-(1,3)dioxolo(4,5-g)isoquino-lin-5-yl)-6,7-dimethoxyisobenzofuran-1(3H)-one
Registry Numbers
0
Heading Mapped to
*Dioxoles
*Isoquinolines
Frequency
13
Note
an antimicrotubule agent and tubulin-binding agent with significant anticancer activity; structure in first source
Source
Blood 2006 Mar 15;107(6):2486-92
Date of Entry
2006/05/28
Revision Date
2009/11/30
EM011 compound Preferred
(S)-3-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-(1,3)dioxolo(4,5-g)isoquino-lin-5-yl)-6,7-dimethoxyisobenzofuran-1(3H)-one Broader
page delivered in 0.004s